What is the share price of Natural Capsules Ltd (NATCAPSUQ) today?
The share price of NATCAPSUQ as on 5th December 2025 is ₹188.44. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Natural Capsules Ltd (NATCAPSUQ) share?
The past returns of Natural Capsules Ltd (NATCAPSUQ) share are- Past 1 week: 9.71%
- Past 1 month: -5.04%
- Past 3 months: -9.44%
- Past 6 months: -25.88%
- Past 1 year: -24.49%
- Past 3 years: N/A%
- Past 5 years: -24.49%
What are the peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ)?
The peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ) include:What is the market cap of Natural Capsules Ltd (NATCAPSUQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Natural Capsules Ltd (NATCAPSUQ) is ₹194.87 Cr as of 5th December 2025.What is the 52 week high and low of Natural Capsules Ltd (NATCAPSUQ) share?
The 52-week high of Natural Capsules Ltd (NATCAPSUQ) is ₹296 and the 52-week low is ₹164.What is the PE and PB ratio of Natural Capsules Ltd (NATCAPSUQ) stock?
The P/E (price-to-earnings) ratio of Natural Capsules Ltd (NATCAPSUQ) is 324.78. The P/B (price-to-book) ratio is 0.76.Which sector does Natural Capsules Ltd (NATCAPSUQ) belong to?
Natural Capsules Ltd (NATCAPSUQ) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Natural Capsules Ltd (NATCAPSUQ) shares?
You can directly buy Natural Capsules Ltd (NATCAPSUQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Natural Capsules Ltd
NATCAPSUQ Share Price
188.442.28% (-4.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NATCAPSUQ Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NATCAPSUQ Performance & Key Metrics
NATCAPSUQ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -16.31 | 0.76 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
NATCAPSUQ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NATCAPSUQ Company Profile
Natural Capsules Ltd specializes in manufacturing hard capsule shells for the pharmaceutical and nutraceutical industries with facilities in Bengaluru and Puducherry.
SUNPHARMA
PE Ratio
39.63
39.63
1Y Return
0.45%
0.45%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.04
67.04
1Y Return
12.63%
12.63%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.51%
1.51%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.77
18.77
1Y Return
2.85%
2.85%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.21
29.21
1Y Return
1.24%
1.24%
Buy Reco %
72.22
72.22
NATCAPSUQ Sentiment Analysis
NATCAPSUQ Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
NATCAPSUQ Stock Summary · November 2025
In the face of significant market challenges, including regulatory changes and tariff impacts, the company is strategically investing in capacity expansion and R&D to enhance resilience and address operational hurdles. Despite a slight revenue increase, declining EBITDA margins and operational losses in the API division underscore the financial strain, prompting a cautious outlook on future guidance. The company is focused on improving production capabilities, particularly in HPMC capsules, while navigating competitive pressures from both domestic and international players. Efforts to establish a fully backward integrated plant aim to reduce reliance on imports and attract US customers, reflecting a commitment to long-term growth amidst current uncertainties. Overall, while optimism exists for regaining momentum, the path forward requires careful management of external factors and operational efficiencies.
NATCAPSUQ Stock Growth Drivers
NATCAPSUQ Stock Growth Drivers
6Capacity Expansion and Production Milestones
The company has successfully executed capacity expansion plans, particularly with the new HPMC production line,
Positive Export Performance
Despite challenges, the company has achieved a 13% increase in exports over the past year.
NATCAPSUQ Stock Challenges
NATCAPSUQ Stock Challenges
6Declining Financial Performance
The company has reported a net loss of Rs. 6.99 crores in Q2 FY'26, with
Regulatory and Tariff Challenges
Significant regulatory changes, particularly tariffs on Indian exports to the U.S., have negatively impacted demand
NATCAPSUQ Forecast
NATCAPSUQ Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NATCAPSUQ
NATCAPSUQ
Income
Balance Sheet
Cash Flow
Annual Normal View
NATCAPSUQ Income Statement
NATCAPSUQ Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 55.57 | 60.92 | 62.50 | 82.42 | 136.08 | 172.94 | 157.36 | 169.91 | 180.73 | |||||||||
Raw Materials | 23.54 | 22.80 | 27.92 | 36.10 | 57.99 | 83.86 | 85.48 | 86.88 | 171.72 | |||||||||
| Power & Fuel Cost | 6.79 | 8.89 | 8.16 | 8.51 | 11.90 | 13.75 | 15.19 | 15.83 | ||||||||||
| Employee Cost | 5.23 | 5.57 | 5.91 | 6.97 | 8.48 | 9.51 | 11.00 | 12.67 | ||||||||||
| Selling & Administrative Expenses | 9.47 | 8.89 | 8.99 | 9.76 | 16.95 | 23.00 | 18.30 | 22.62 | ||||||||||
| Operating & Other expenses | 4.19 | 8.97 | 5.13 | 7.08 | 14.25 | 6.89 | 5.39 | 13.47 | ||||||||||
EBITDA | 6.35 | 5.80 | 6.39 | 14.00 | 26.51 | 35.93 | 22.00 | 18.44 | 9.01 | |||||||||
| Depreciation/Amortization | 4.33 | 3.20 | 4.12 | 4.31 | 5.04 | 7.21 | 8.67 | 9.12 | 12.99 | |||||||||
| PBIT | 2.02 | 2.60 | 2.27 | 9.69 | 21.47 | 28.72 | 13.33 | 9.32 | -3.98 | |||||||||
| Interest & Other Items | 0.33 | 0.53 | 0.91 | 0.54 | 2.08 | 3.73 | 5.27 | 6.54 | 8.39 | |||||||||
| PBT | 1.69 | 2.07 | 1.36 | 9.15 | 19.39 | 24.99 | 8.06 | 2.78 | -12.37 | |||||||||
| Taxes & Other Items | 0.57 | 0.14 | 0.52 | 2.24 | 5.47 | 6.55 | 2.50 | 2.18 | -0.42 | |||||||||
| Net Income | 1.12 | 1.93 | 0.84 | 6.91 | 13.92 | 18.44 | 5.56 | 0.60 | -11.95 | |||||||||
| EPS | 1.47 | 2.54 | 1.11 | 9.09 | 19.05 | 22.64 | 5.97 | 0.61 | -11.56 | |||||||||
| DPS | 0.82 | 0.82 | 0.49 | 0.82 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Payout ratio | 0.56 | 0.32 | 0.45 | 0.09 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 |
NATCAPSUQ Company Updates
FY 2026FY 2026
Investor Presentation
Nov 14PDF
Aug 5PDF
NATCAPSUQ Stock Peers
NATCAPSUQ Past Performance & Peer Comparison
NATCAPSUQ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Natural Capsules Ltd | 324.78 | 0.76 | — |
| Sun Pharmaceutical Industries Ltd | 39.63 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.04 | 16.88 | 0.85% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
NATCAPSUQ Stock Price Comparison
Compare NATCAPSUQ with any stock or ETFCompare NATCAPSUQ with any stock or ETF
NATCAPSUQ
NATCAPSUQ Holdings
NATCAPSUQ Shareholdings
NATCAPSUQ Promoter Holdings Trend
NATCAPSUQ Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NATCAPSUQ Institutional Holdings Trend
NATCAPSUQ Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NATCAPSUQ Shareholding Pattern
NATCAPSUQ Shareholding Pattern
NATCAPSUQ Shareholding History
NATCAPSUQ Shareholding History
Foreign Institutions
smallcases containing NATCAPSUQ stock
smallcases containing NATCAPSUQ stock
Looks like this stock is not in any smallcase yet.
NATCAPSUQ Events
NATCAPSUQ Events
NATCAPSUQ Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NATCAPSUQ Dividend Trend
No dividend trend available
NATCAPSUQ Upcoming Dividends
NATCAPSUQ Upcoming Dividends
No upcoming dividends are available
NATCAPSUQ Past Dividends
NATCAPSUQ Past Dividends
Cash Dividend
Ex DateEx DateJul 20, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
Cash Dividend
Ex DateEx DateSep 9, 2022
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 9, 2022
Cash Dividend
Ex DateEx DateJul 6, 2021
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 6, 2021
Cash Dividend
Ex DateEx DateAug 12, 2020
Final
Final | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Aug 12, 2020
Cash Dividend
Ex DateEx DateAug 13, 2019
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 13, 2019
NATCAPSUQ Stock News & Opinions
NATCAPSUQ Stock News & Opinions
Articles & Videos
Earnings
Natural Capsules reports consolidated net loss of Rs 6.99 crore in the September 2025 quarter
Net Loss of Natural Capsules reported to Rs 6.99 crore in the quarter ended September 2025 as against net loss of Rs 0.61 crore during the previous quarter ended September 2024. Sales rose 11.11% to Rs 45.80 crore in the quarter ended September 2025 as against Rs 41.22 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales45.8041.22 11 OPM %-1.9210.92 - PBDT-3.412.96 PL PBT-7.690.62 PL NP-6.99-0.61 -1046 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Natural Capsules to convene board meeting
Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Natural Capsules reports consolidated net loss of Rs 5.58 crore in the June 2025 quarter
Net loss of Natural Capsules reported to Rs 5.58 crore in the quarter ended June 2025 as against net profit of Rs 0.60 crore during the previous quarter ended June 2024. Sales rose 15.36% to Rs 45.20 crore in the quarter ended June 2025 as against Rs 39.18 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales45.2039.18 15 OPM %0.7111.15 - PBDT-1.853.06 PL PBT-6.060.78 PL NP-5.580.60 PL Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Natural Capsules to declare Quarterly Result
Natural Capsules will hold a meeting of the Board of Directors of the Company on 4 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Natural Capsules to conduct AGM
Natural Capsules announced that the 32th Annual General Meeting(AGM) of the company will be held on 4 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Natural Capsules consolidated net profit declines 46.39% in the March 2025 quarter
Net profit of Natural Capsules declined 46.39% to Rs 0.52 crore in the quarter ended March 2025 as against Rs 0.97 crore during the previous quarter ended March 2024. Sales rose 11.81% to Rs 44.97 crore in the quarter ended March 2025 as against Rs 40.22 crore during the previous quarter ended March 2024. For the full year,net profit declined 88.83% to Rs 0.62 crore in the year ended March 2025 as against Rs 5.55 crore during the previous year ended March 2024. Sales rose 8.87% to Rs 169.21 crore in the year ended March 2025 as against Rs 155.42 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales44.9740.22 12 169.21155.42 9 OPM %9.7610.22 -10.3512.81 - PBDT3.053.63 -16 11.9116.72 -29 PBT0.891.43 -38 2.798.05 -65 NP0.520.97 -46 0.625.55 -89 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Natural Capsules declare Quarterly Result
Natural Capsules will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Natural Capsules consolidated net profit declines 90.91% in the December 2024 quarter
Net profit of Natural Capsules declined 90.91% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 1.21 crore during the previous quarter ended December 2023. Sales rose 9.63% to Rs 43.83 crore in the quarter ended December 2024 as against Rs 39.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales43.8339.98 10 OPM %9.7411.81 - PBDT2.843.98 -29 PBT0.501.79 -72 NP0.111.21 -91 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Natural Capsules schedules board meeting
Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Natural Capsules reports consolidated net loss of Rs 0.61 crore in the September 2024 quarter
Net loss of Natural Capsules reported to Rs 0.61 crore in the quarter ended September 2024 as against net profit of Rs 1.56 crore during the previous quarter ended September 2023. Sales rose 9.86% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 37.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales41.2237.52 10 OPM %10.9213.65 - PBDT2.964.31 -31 PBT0.622.14 -71 NP-0.611.56 PL Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 22.14%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.02% to 0.04%
Over the last 5 years, net income has grown at a yearly rate of -6.51%, vs industry avg of 20.02%